Assignee
INSILICO MEDICINE IP LTD
HK·33 granted patents·44 pending applications·38 citations·filing 2019–2025
Top patents by PatentIndex Score
77 records- 0194US11795160B2Kinase inhibitorsINSILICO MEDICINE IP LTD·Filed 2020·Granted Oct 24, 2023·5 cites·9 claims
- 0294US11739078B2Methods of inhibiting kinasesINSILICO MEDICINE IP LTD·Filed 2020·Granted Aug 29, 2023·5 cites·21 claims
- 0393US11739077B2Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 29, 2023·2 cites·30 claims
- 0492US12227493B2Methods of inhibiting kinasesINSILICO MEDICINE IP LTD·Filed 2023·Granted Feb 18, 2025·1 cites·16 claims
- 0592US11731987B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 22, 2023·3 cites·30 claims
- 0692US11530197B2Analogs for the treatment of diseaseINSILICO MEDICINE IP LTD·Filed 2022·Granted Dec 20, 2022·3 cites·28 claims
- 0791US11834440B2Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2023·Granted Dec 5, 2023·2 cites·30 claims
- 0890US11893498B2Subset conditioning using variational autoencoder with a learnable tensor train induced priorINSILICO MEDICINE IP LTD·Filed 2023·Granted Feb 6, 2024·4 cites·20 claims
- 0990US11780854B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Oct 10, 2023·1 cites·29 claims
- 1089US11530199B2Analogs for the treatment of diseaseINSILICO MEDICINE IP LTD·Filed 2022·Granted Dec 20, 2022·2 cites·30 claims
- 1188US11008303B2TLR 9 inhibitorsINSILICO MEDICINE IP LTD·Filed 2020·Granted May 18, 2021·2 cites·21 claims
- 1286US11731944B2SARS-CoV-2 inhibitors for treating coronavirus infectionsINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 22, 2023·1 cites·27 claims
- 1385US12307379B2Subset conditioning using variational autoencoder with a learnable tensor train induced priorINSILICO MEDICINE IP LTD·Filed 2023·Granted May 20, 2025·1 cites·20 claims
- 1485US2026062403A1Kinase inhibitorsINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 1583US12410156B2Kinase inhibitorsINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 9, 2025·0 cites·12 claims
- 1683US11680063B2Entangled conditional adversarial autoencoder for drug discoveryINSILICO MEDICINE IP LTD·Filed 2019·Granted Jun 20, 2023·5 cites·22 claims
- 1781US12209101B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Jan 28, 2025·0 cites·14 claims
- 1881US12071443B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 27, 2024·0 cites·21 claims
- 1981US10988457B2TLR inhibitorsINSILICO MEDICINE IP LTD·Filed 2020·Granted Apr 27, 2021·1 cites·22 claims
- 2080US12570634B2Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Mar 10, 2026·0 cites·11 claims
- 2179US12091406B2Lysine acetyltransferase 6A (KAT6A) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 17, 2024·0 cites·20 claims
- 2278US12162862B2Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2023·Granted Dec 10, 2024·0 cites·25 claims
- 2378US2026015349A1Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 2478US2025034132A1Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 2578US2025163031A1Beta-lactam derivatives for the treatment of diseasesINSILICO MEDICINE IP LTD·Filed 2024·Application pending·0 cites
- 2674US2025225389A1Mutual information adversarial autoencoderINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 2773US12583838B2Analogs for the treatment of diseaseINSILICO MEDICINE IP LTD·Filed 2022·Granted Mar 24, 2026·0 cites·12 claims
- 2873US11999713B2Methionine adenosyltransferase 2a (MAT2A) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Jun 4, 2024·0 cites·20 claims
- 2973US2025026754A1Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereofINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 3073US2024109880A1Lysine acetyltransferase 6a (kat6a) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3172US2024025860A1Sars-cov-2 inhibitors for treating coronavirus infectionsINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3272US2024174635A1Tlr 9 inhibitorsINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3371US12077538B2Diacylglycerol kinase (DGK) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 3470US12282851B2Mutual information adversarial autoencoderINSILICO MEDICINE IP LTD·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 3570US2023253076A1Local steps in latent space and descriptors-based molecules filtering for conditional molecular generationINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3670US2025182858A1Large Language Model for Unified Text and Point Cloud Molecular InputINSILICO MEDICINE IP LTD·Filed 2024·Application pending·0 cites
- 3769US2026049062A1Sars-cov-2 inhibitors for treating coronavirus infectionsINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 3869US2023331723A1Entangled conditional adversarial autoencoder for drug discoveryINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3968US2024051958A1Diacylglycerol kinase (dgk) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 4068US2026100252A1Advanced retrosynthesis-related synthetic accessibility modelingINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 4165US2025042890A1METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOFINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 4264US12103915B2TEAD inhibitors and methods of uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Oct 1, 2024·0 cites·26 claims
- 4364US11807622B2TLR 9 inhibitorsINSILICO MEDICINE IP LTD·Filed 2021·Granted Nov 7, 2023·0 cites·19 claims
- 4464US2025340569A1Inhibitors of kif18a and uses thereofINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 4564US2021383898A1Graph normalizing flow for hierarchical molecular generationINSILICO MEDICINE IP LTD·Filed 2021·Application pending·0 cites
- 4664US2026004129A1Structure-based deep generative model for binding site descriptors extraction and de novo molecular generationINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 4763US12462900B2Retrosynthesis systems and methodsINSILICO MEDICINE IP LTD·Filed 2021·Granted Nov 4, 2025·0 cites·23 claims
- 4863US12380329B2Structure-based deep generative model for binding site descriptors extraction and de novo molecular generationINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 5, 2025·0 cites·22 claims
- 4963US2025188094A1Pyrazole membrane-associated tyrosine-and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 5063US2025163077A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INSILICO MEDICINE IP LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →